Exosomes Engineering and Their Roles as Therapy Delivery Tools, Therapeutic Targets, and Biomarkers

Abstract

Exosomes are becoming increasingly important therapeutic biomaterials for use in a variety of therapeutic applications due to their unique characteristics, especially due to the ineffectiveness and cytotoxicity of some existing therapies and synthetic therapeutic nanocarriers. They are highly promising as carriers of drugs, genes, and other therapeutic agents that can be incorporated into their interior or onto their surface through various modification techniques to improve their targeting abilities. In addition, they are biocompatible, safe, and stable. The review focuses on different types of exosomes and methods of their preparation, including the incorporation of different kinds of cargo, especially for drug delivery purposes. In particular, their importance and effectiveness as delivery vehicles of various therapeutic agents for a variety of therapeutic applications, including different diseases and disorders such as cancer treatment, cardiovascular and neurodegenerative diseases, are emphasized. Administration routes of exosomes into the body are also included. A novelty in the article is the emphasis on global companies that are already successfully developing and testing such therapeutic biomaterials, with a focus on the most influential ones. Moreover, a comparison of the advantages and disadvantages of the various methods of exosome production is summarized for the first time.

Extracellular Vesicles and Acute Kidney Injury: Potential Therapeutic Avenue for Renal Repair and Regeneration

“…For EVs-based therapies to enter routine clinical use, it will be necessary both to elucidate their mechanism of action and enhance their targeting. Enhancement of the targeting properties of EVs can be achieved by adding/enriching the EVs’ surfaces with molecules that recognize specific cells (antibodies, ligands, receptors, and sugar moieties) or by incorporating molecules on their surfaces that are activated at target sites (i.e., in tumor environment) [ 196 ].…”

Exosomes in Age-Related Cognitive Decline: Mechanistic Insights and Improving Outcomes

“…Compared to traditional drug delivery, exosomes offer a number of benefits including their capacity to translocate functional biomolecules, their stability in blood, and immune tolerance ( Pêche et al, 2006 ; Sun et al, 2013 ; Song et al, 2016 ). Naturally occurring exosomes derived from a variety of sources have been investigated for therapeutic applications, including those from different mammalian cells (e.g., mesenchymal stem cells, macrophages, tumor cells), plant cells, and biological fluids (e.g., plasma, serum, and milk) ( Luan et al, 2017 ; Alfieri et al, 2021 ; Kučuk et al, 2021 ; Perut et al, 2021 ). Isolated exosomes can be exogenously loaded with therapeutic cargo for targeted delivery, ranging from RNAs (siRNA, miRNA, lncRNA) and proteins to synthetic chemicals and drugs.…”

Current and prospective applications of exosomal microRNAs in pulmonary fibrosis (Review)

“…Depending on their biosynthesis, particle size and biophysical properties, EVs can be classified into four subtypes as follows: Exosomes, microvesicles (MVs) or micropaticles ( 19 ) and apoptotic bodies ( 20 , 21 ), as well as smaller-diameter subsets of nanoparticle exomeres ( 22 , 23 ). Different subtypes of EVs can be enriched and broadly separated using different methods, such as ultracentrifugation, ultrafiltration, polymer precipitation, immunoaffinity chromatography, flow cytometry, density gradient centrifugation, microfluidics-based techniques and immunoadsorption ( 24 ). Currently, the gold standard for EVs isolation is the ultracentrifugation-linked immunoprecipitation method ( 25 ).…”